Combining Daratumumab with VRd Improves Outcomes in Patients with Transplant-Ineligible or Transplant-Deferred Newly Diagnosed Multiple Myeloma By Ogkologos - March 3, 2025 835 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the CEPHEUS study Source RELATED ARTICLESMORE FROM AUTHOR Giredestrant plus everolimus prolongs PFS among patients with ER-positive, HER2-negative, ESR1-mutated advanced breast cancer after the receipt of a CDK4/6 inhibitor EMA Recommends Granting a Marketing Authorisation for Ensartinib Taking on the RAS Challenge MOST POPULAR Female Representation at the Top of the Oncology Field Has Hit... October 20, 2021 How People With Cancer Can Benefit From Online Therapy October 22, 2020 From athlete to wig-maker: how cancer changed Maria’s destiny December 16, 2022 Oncolytic Virus Enables the Immune System to Attack Tumors October 12, 2023 Load more HOT NEWS FDA Approves Margetuximab for Metastatic HER2-positive Breast Cancer Fear Study Suggests that Cancer Patients Who Eat Peanuts Frequently May Be... First-Line Treatment with Atezolizumab Associated with Improved OS in Patients with...
